![Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology](https://ala.associates/wp-content/uploads/2016/11/Pascal-Neuville-2016-e1478702603628-992x675.jpg)
![Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology](https://ala.associates/wp-content/uploads/2016/11/Pascal-Neuville-2016-e1478702603628-992x675.jpg)
![Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics](https://ala.associates/wp-content/uploads/2017/02/Photo-Marc-Martinell-2015-1080x675.jpg)
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics
![Nosopharm receives €1 million loan from Bpifrance](https://ala.associates/wp-content/uploads/2017/03/Nosopharm_Photo-P-VILLAIN-GUILLOT-1-e1490620166209-1080x675.jpg)
Nosopharm receives €1 million loan from Bpifrance
![GamaMabs Pharma receives Orphan Drug Designation from the US FDA for lead compound GM102](https://ala.associates/wp-content/uploads/2017/10/SDegove-1080x675.jpg)
GamaMabs Pharma receives Orphan Drug Designation from the US FDA for lead compound GM102
![VitriCell raises over €1 million ($1.2M) in series A funding](https://ala.associates/wp-content/uploads/2018/01/VitriCell-Cell-Website-1080x675.jpg)
VitriCell raises over €1 million ($1.2M) in series A funding
![Univercells granted €2.4M ($2.9M) to develop antibody production platform](https://ala.associates/wp-content/uploads/2018/01/Univercells-wallonia.jpg)
Univercells granted €2.4M ($2.9M) to develop antibody production platform
![BioAxial granted US patent covering ‘black fluorophore’ technology](https://ala.associates/wp-content/uploads/2018/01/Georges-Tabary-1080x675.jpg)
BioAxial granted US patent covering ‘black fluorophore’ technology
Genopole lance l’appel à candidatures pour la 2e promotion du Shaker et du Booster
![Antibiotic resistance: Pherecydes Pharma raises €8.7M ($10.3M)](https://ala.associates/wp-content/uploads/2018/01/GC-Fanneau-de-La-Horie-1080x675.jpg)
Antibiotic resistance: Pherecydes Pharma raises €8.7M ($10.3M)
![SparingVision sélectionnée pour une présentation publique au 10e Biotech Showcase™](https://ala.associates/wp-content/uploads/2018/01/FAG-Bureau-1080x675.jpg)